Harvard Bioscience (HBIO) Current Leases (2019 - 2026)
Harvard Bioscience (HBIO) posted quarterly Current Leases of $1.6 million for Q1 2026, up 9.37% year-over-year from $1.4 million in Q1 2025, and up 1.77% quarter-over-quarter from $1.5 million in Q4 2025.
Harvard Bioscience (HBIO) Current Leases (2019 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Current Leases for 8 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases rose 9.37% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 9.37% YoY), while the FY2025 annual figure was $1.5 million, up 31.69% from the prior year.
- Current Leases advanced to $1.6 million in Q1 2026 per HBIO's latest filing, from $1.5 million in the prior quarter.
- Across five years, Current Leases topped out at $2.2 million in Q1 2022 and bottomed at $1.1 million in Q2 2024.
- Historically, Current Leases has averaged $1.7 million across 5 years, with a median of $1.5 million in 2025.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 50.21% — and 2025, when it surged 37.33%.
- Harvard Bioscience's Current Leases stood at $2.1 million in 2022, then slumped by 33.68% to $1.4 million in 2023, then fell by 18.22% to $1.2 million in 2024, then soared by 31.69% to $1.5 million in 2025, then grew by 1.77% to $1.6 million in 2026.
- Business Quant data shows HBIO's Current Leases at $1.6 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 135.10 Bn | 129.88 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.53 Bn | 51.67 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.80 Bn | 34.45 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.98 Bn | 32.51 Bn | 861.22 Mn | 29.14 Mn |
| 5 | Medline | 29.15 Bn | 26.47 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 24.98 Bn | 24.54 Bn | 329.20 Mn | 20.90 Mn |
| 7 | Solventum | 15.36 Bn | 14.96 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.87 Bn | 14.73 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 33.90 Mn | 27.40 Mn | 12.63 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.53 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 1.06 Mn |
| Mar 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 2.13 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 2.14 Mn |
| Sep 30, 2022 | 2.12 Mn |
| Jun 30, 2022 | 2.11 Mn |
| Mar 31, 2022 | 2.15 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 2.13 Mn |